Design of a 24-hour controlled porosity osmotic pump system containing PVP: Formulation variables

Drug Development and Industrial Pharmacy

Volumn 35, Issue 12, 2009, Pages 1430-1438

  Yakubu, Rabiu ^a   Peh, Kok K ^a   Tan, Yvonne T F ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Controlled porosity osmotic pump design; Formulation variables; Ketoprofen; Polyvinyl pyrrolidone; Pseudoephedrine HCl

Indexed keywords

GLUCOSE; KETOPROFEN; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; POVIDONE; PSEUDOEPHEDRINE;

ARTICLE; CONTROLLED POROSITY OSMOTIC PUMP; DELAYED DRUG RELEASE; DRUG COATING; DRUG GRANULATION; POROSITY; TABLET FORMULATION;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; KETOPROFEN; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; OSMOSIS; PHARMACEUTIC AIDS; POROSITY; POVIDONE; PSEUDOEPHEDRINE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; VISCOSITY;

EID: 71049167647     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040902988566     Document Type: Article

References (37)

1. Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. (1995). Asymmetric-membrane tablet coating for osmotic drug delivery. J Control Release, 35:127-136
2. Prabakaran D, Singh P, Kanaujia P, Vyas SP. (2003). Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pump. Int J Pharm, 259:173-179
3. Gupta PK, Robinson JR. (1992). Oral controlled release delivery. In: Kydonie A, ed. Treatise on controlled drug delivery. New York: Marcel Dekker, Inc., 255-313
4. Verma RK, Krishna DM, Garg S. (2002). Formulation aspect in the development of osmotically controlled oral drug delivery systems. J Control Release, 79:7-27
5. Okimoto K, Tokunaga Y, Ibuki R, Irie T, Uekama K, Rajewski RA, et al. (2004). Applicabiity of (SBE)7m-?-CD in controlledporosity osmotic pump tablets (OPTs). Int J Pharm, 286:81-88
6. Shokri J, Ahmadi P, Rashidi P, Shahsavari M, Rajabi-Siahboomi A, Nokhodchi A. (2008). Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm, 68:289-297
7. Srinkonda S, Kotamrai P, Barclay B. (2006). Osmotic controlled drug delivery systems. In: Li X, Jastin BR, eds. Design of controlled release delivery systems. New York: The McGraw-Hill Companies, Inc., 203-230
8. Liu L, Khang G, Rhee JM, Lee HB. (2000). Monolithic osmotic system for nifedipine. J Control Release, 67:309-322
9. Lu E, Jiang Z, Zhang O, Jiang X. (2003). A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic and expanding agent. J Control Release, 92:375-382
10. Prabakaran D, Singh P, Kanaujia P, Jaganathan KS, Rawat A, Vyas SP. (2004). Controlled porosity osmotic pumps for highly aqueous soluble drug containing hydrophilic polymers as release retardants. Pharm Dev Technol, 9:435-442
11. Handbook of Pharmaceutical Excipients. (1994). 2nd ed. London: The Pharmaceutical Press
12. Edgar KJ, Buchanan CM, Debenham JS, Rundquist PA, Seiler BD, Shelton MC, et al. (2001). Advances in cellulose ester performance and application. Prog Polym Sci, 26:1605-88.
13. Am Ende MT, Herbig SM, Korsmeyer RW, Chidlaw MB. (2000). Osmotic drug delivery from asymmetric membrane film-coated dosage forms. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: Mercel Dekker, Inc., 751-785
14. Okimoto K, Miyeki M, Ohnishi N, Rajewski RA, Stella VJ, Irie T, et al. (1998). Design and evaluation of an osmotic pump system for prednisolone, a poorly water soluble drug, using (SBE)7M- ?-CD. Pharm Res, 15(10):1562-1568
15. Okimoto K, Ohike A, Ibuki R, Aoki O, Onishi N, Rajewski RA, et al. (1999). Factors affecting membrane-controlled drug release for an osmotic pump tablet utilizing (SBE)7m-CD as both solubilizer and osmotic agent. J Control Release, 60:311-319 (Pubitemid 29335956)
16. Makhija SP, Vavia PR. (2003). Controlled porosity osmotic pump-based controlled release systems of pseudo - ephedrine
17. Cellulose acetate as a semi-permeable membrane. J Control Release, 89(1):5-18
18. Lin W, Lee H. (2003). Design for a microporous controlled delivery system for theophylline. J Control Release, 98(8):179-187
19. Meier MM, Kanis LA, Soldi V. (2004). Characterization and drug-permeation profiles of microporous and dense cellulose acetate membranes: Influence of plasticizer and pore-forming agent. Int J Pharm, 278(1):99-110
20. Verma RK, Garg S. (2004). Development and evaluation of osmotically controlled oral drug delivery system of glypizide. Eur J Pharm Biopharm, 57:513-525
21. Zhang Z, Li W, Nie S, Tang X, Peng B, Tian L, et al. (2009). Overcome side identification in PPOP by making orifices on both layers. Int J Pharm, 371(1-2):1-7
22. Garg A, Gupta M, Bhargava HM. (2007). Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Eur J Pharm Biopharm, 67:725-731
23. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. (2004). Polymer blends used for the aqueous coating of solid dosage forms: Importance of the type of plasticizer. J Control Release, 99:1-13
24. Savastano L, Levenberger H, Merkle HP. (1995). Membrane modulated dissolution of oral drug delivery systems. Pharm Acta Helv, 70:117-124
25. Narisawa S, Nagata M, Hirakawa Y, Kobayashi M, Yoshino H. (1997). An organic acid-induced sigmoidal release system for oral controlled-release preparations. III: Elucidation of the anomalous drug release behavior through osmotic pumping mechanism. Int J Pharm, 148:85-91
26. Thombre AG, Appel LE, Chidlaw MB, Daugherity FD, Evans LAF, Sutton SC. (2004). Osmotic drug delivery using swellablecore technology. J Control Release, 94(1):75-89
27. Malaterre V, Pedersen M, Ogorka J, Gurny R, Loggia N, Taday PF. (2009). Terahertz pulse imaging, a novel process analytical tool to investigate the coating characteristics of push-pull osmotic systems. Eur Pharm Biopharm, in press
28. Jerzewski RL, Chien YW. (1992). Osmotic drug delivery. In: Kydonieus A, ed. Treatise on controlled drug delivery. New York: Mercel Dekker, Inc., 225-253
29. Jantzen GM, Robinson JR. (1996). Sustained- and controlled- release drug delivery systems. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. New York: Mercel Dekker, Inc., 575-609
30. Venkatraman S, Danar N, Chester A, Kleiner L. (2000). An overview of controlled release systems. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: Mercel Dekker, Inc., 431-463
31. Ozdemir N, Sahin J. (1997). Design of a controlled release osmotic pump system of Ibuprofen. Int J Pharm, 57:817-820
32. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. (2000). Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release, 68:145-156 (Pubitemid 30488892)
33. Li X, Pan W, Nie S, Wu L. (2004). Study on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe. J Control Release, 96:359-367
34. Zentner GM, Rork GS, Himmelstein KJ. (1985). The controlled porosity osmotic pump. J Control Release, 4(1):269-282
35. Zentner GM, Rork GS, Himmelstein KJ. (1985). Osmotic flow through controlled porosity film: An approach to delivery of water soluble compounds. J Control Release, 2:217-229
36. Liu LX, Xu Q, Khang G, Rhee JM, Lee HB. (2003). Unitary-core osmotic pump tablet for the controlled release of waterinsoluble drug. Yao Xue Xue Bao, 38(12):966-967
37. International Specialty Products. (1999). Plasdone Povidone USP Technical Profile. PLAS/10M/399. New Jersey 07470